Ionis Pharmaceuticals (IONS) Gross Profit (2018 - 2025)
Ionis Pharmaceuticals (IONS) has 8 years of Gross Profit data on record, last reported at $154.4 million in Q3 2025.
- For Q3 2025, Gross Profit rose 16.3% year-over-year to $154.4 million; the TTM value through Sep 2025 reached $781.1 million, up 37.67%, while the annual FY2024 figure was $693.9 million, 10.87% down from the prior year.
- Gross Profit reached $154.4 million in Q3 2025 per IONS's latest filing, down from $273.8 million in the prior quarter.
- Across five years, Gross Profit topped out at $321.4 million in Q4 2023 and bottomed at -$4.1 million in Q2 2024.
- Average Gross Profit over 5 years is $140.5 million, with a median of $132.7 million recorded in 2024.
- Peak YoY movement for Gross Profit: skyrocketed 17082.63% in 2022, then tumbled 102.22% in 2024.
- A 5-year view of Gross Profit shows it stood at $57.8 million in 2021, then surged by 156.52% to $148.2 million in 2022, then soared by 116.89% to $321.4 million in 2023, then tumbled by 30.7% to $222.7 million in 2024, then plummeted by 30.69% to $154.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Gross Profit were $154.4 million in Q3 2025, $273.8 million in Q2 2025, and $130.1 million in Q1 2025.